Adalimumab
Links shared publicly online about this topic
Rheumatology Medical News about adalimumab
mdlinx.com — “Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab” View full resource at mdlinx.com
Most Recently Shared on June 16, 2010 at 4:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab: Clinical Rheumatology http://bit.ly/bs9R9O #Rheumatology
ingentaconnect Adalimumab: Subacute liver failure: case report
ingentaconnect.com — “ingentaconnect Adalimumab: Subacute liver failure: case report” View full resource at ingentaconnect.com
Most Recently Shared on February 28, 2011 at 8:44 am By:
Urology & Nephrology OW Health
Adalimumab: Subacute liver failure: case report: (Source: Reactions) http://bit.ly/fihzFt
ingentaconnect Efficacy and safety of adalimumab in patients with psoriasis prev...
ingentaconnect.com — “ingentaconnect Efficacy and safety of adalimumab in patients with psoriasis prev...” View full resource at ingentaconnect.com
Most Recently Shared on August 9, 2011 at 1:33 pm By:
PsoriasisTx.com Dermatology and Health Site
Adalimumab effective in #psoriasis pts previously treated with anti-TNF agents. Subanalysis of BELIEVE trial. http://ow.ly/5YGzL
Adalimumab may decrease vascular inflammation in patients with psoriasis
news-medical.net — “A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.” View full resource at news-medical.net
Most Recently Shared on March 17, 2012 at 5:19 am By:
Adalimumab may decrease vascular inflammation in patients with psoriasis: A clinical study co-led by the Montrea... http://t.co/23ZWMSBu
Adalimumab may decrease vascular inflammation in patients with psoriasis
news-medical.net — “A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.” View full resource at news-medical.net
Most Recently Shared on March 17, 2012 at 7:38 am By:
Adalimumab may decrease vascular inflammation in patients with psoriasis: A clinical study co-led by the Montrea... http://t.co/lYzmJMfP
ingentaconnect Adalimumab/infliximab: Psoriasis: case report
ingentaconnect.com — “ingentaconnect Adalimumab/infliximab: Psoriasis: case report” View full resource at ingentaconnect.com
Most Recently Shared on May 12, 2011 at 7:04 am By:
Adalimumab/infliximab: Psoriasis: case report: (Source: Reactions)MedWorm Sponsor Message: Find out how you can ... http://bit.ly/maEP8S
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease
medicalnewstoday.com — “In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not respond” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2010 at 4:37 am By:
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease In final draft guidance.. http://bit.ly/cAsG7S
ingentaconnect Adalimumab: Malignant melanoma in an elderly patient: case report
ingentaconnect.com — “ingentaconnect Adalimumab: Malignant melanoma in an elderly patient: case report” View full resource at ingentaconnect.com
Most Recently Shared on March 22, 2012 at 10:36 am By:
Adalimumab: Malignant melanoma in an elderly patient: case report: (Source: Reactions) http://t.co/i8RRjwxm
ingentaconnect Adalimumab: Malignant melanoma in an elderly patient?: case repor...
ingentaconnect.com — “ingentaconnect Adalimumab: Malignant melanoma in an elderly patient?: case repor...” View full resource at ingentaconnect.com
Most Recently Shared on September 27, 2010 at 6:28 pm By:
Adalimumab: Malignant melanoma in an elderly patient?: case report: (Source: Reactions) http://bit.ly/cZql1c
ingentaconnect Effects of Adalimumab versus Placebo on Risk of Symptom Worsening...
ingentaconnect.com — “ingentaconnect Effects of Adalimumab versus Placebo on Risk of Symptom Worsening...” View full resource at ingentaconnect.com
Most Recently Shared on November 10, 2010 at 7:52 am By:
Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-... http://bit.ly/bTNs6z
Neurology News & Articles - MDLinx - Acute Disease Sciatica; Adalimumab on #MDlinx
mdlinx.com — “Neurology News & Articles - MDLinx - Acute Disease Sciatica; Adalimumab on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 5, 2010 at 7:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-contro... http://bit.ly/duYMwU #neurology #mdlinx
Emergency Medicine News & Articles - MDLinx - Acute Disease Sciatica; Adalimumab on #MDlinx
mdlinx.com — “Emergency Medicine News & Articles - MDLinx - Acute Disease Sciatica; Adalimumab on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 5, 2010 at 11:47 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-controlled tr... http://bit.ly/9vivEO #ER #mdlinx
ingentaconnect The Long-Term Safety of Adalimumab Treatment in Moderate to Sever...
ingentaconnect.com — “ingentaconnect The Long-Term Safety of Adalimumab Treatment in Moderate to Sever...” View full resource at ingentaconnect.com
Most Recently Shared on August 15, 2011 at 1:30 am By:
The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis: A Comprehensive Analysis of All Ad... http://t.co/sg6KDtL
Adalimumab levels detected in cord blood and infants exposed in utero
medicalxpress.com — “Adalimumab (ADA), a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers at the University of California San Francisco have found.” View full resource at medicalxpress.com
Most Recently Shared on May 8, 2011 at 10:26 am By:
PhysOrg Health News Health News
Adalimumab levels detected in cord blood and infants exposed in utero http://tw.medicalxpress.com/224054725
Study: Adalimumab can remain in newborn's bloodstream for at least three months
news-medical.net — “Adalimumab, a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers at the University of California San Francisco have found.” View full resource at news-medical.net
Most Recently Shared on May 9, 2011 at 9:53 am By:
Pregnancy News: Study: Adalimumab can remain in newborn's bloodstream for at least three months: Adalimumab, a d... http://bit.ly/jXr3MG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
-
PsoriasisTx.com
PsoriasisTx.com is a free educational Web site designed to provide dermatology professionals with the latest information about therapies for psoriasis.
Advertisement
